BJDX Total Utang marang Modal Bluejay Diagnostics, Inc.

Lambang korporat lan logo bluejaydx.com (BJDX)

The market value dynamics of the asset help assess the strategy of Bluejay Diagnostics (BJDX), which is based on the FDA approval of the Symphony platform and the sale of disposable cartridges. The current indicator is 0.01. The brand is highly valued by emergency care specialists, which attracts sector-specific funds. Equipping clinics with rapid testing hardware generates additional profit, creating a steady stream of recurring orders for components.

Rasio Utang marang Ekuitas: bluejaydx.com (BJDX) kanggo 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan Bluejay Diagnostics Corp (BJDX)

- rega lan prakiraan konsensus rega:
Bagan rega Bluejay Diagnostics, Inc.|BJDX - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Bluejay Diagnostics|BJDX - Total Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham Bluejay Diagnostics|BJDX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku bluejaydx.com|BJDX - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Bluejay Diagnostics|BJDX - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Bluejay Diagnostics|BJDX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Bluejay Diagnostics
Ringkesan analisis perusahaan:BJDX, Bluejay Diagnostics, Inc.
Produk mawa merek Bluejay Diagnostics Corp

For Bluejay Diagnostics (BJDX), which is developing the Symphony platform and rapid tests for intensive care units, the balance between debt and equity determines stability during product commercialization. Analyzing the total liabilities-to-equity ratio allows for an assessment of over-leverage risk, where an increase in the metric signals dependence on creditors, while a decrease confirms financial autonomy and asset quality.

Analisis perusahaan pesaing

Utang marang Ekuitas A|Rasio Total Utang marang Ekuitas Quest Diagnostics Inc.|Illumina Corp - Total Utang marang Modal|Utang marang Modal Exact Sciences Inc. (EXAS)|RVTY - Total Utang marang Modal|Rasio Utang marang Ekuitas bio-rad.com BIO|Anbio - Total Utang marang Modal|SHC: Total Utang marang Modal|Utang marang Ekuitas QuidelOrtho Corp|OPKO Health Corp. (OPK) - Rasio Utang marang Ekuitas|CDNA (CareDx Inc) - Total Utang marang Modal|Total Utang marang Modal MRVI|Utang marang Ekuitas Fulgent Genetics (FLGT)|Utang marang Ekuitas Standard BioTools Inc LAB|CTKB: Rasio Total Utang marang Ekuitas|OraSure Corp - Utang marang Modal|Utang marang Ekuitas XGN (Exagen Diagnostics)|MDXH - Koefisien Total Utang marang Modal|Lucid Diagnostics - Total Utang marang Modal|PRE (Prenetics) - Koefisien Total Utang marang Modal|IMDX: Utang marang Ekuitas|Koefisien Total Utang marang Modal Trinity Biotech Corp|Total Utang marang Modal ProPhase Labs, Inc. (PRPH)|Utang marang Ekuitas AIMD (ainos.com)|Utang marang Ekuitas Co-Diagnostics CODX|HSCS - Utang marang Ekuitas|Biomerica, Inc - Rasio Total Utang marang Ekuitas|CDIO - Total Utang marang Modal|Total Utang marang Modal VRAX|AWH (aspirawh.com) - Utang marang Modal|Accelerate Diagnostics, Inc. (AXDX) - Utang marang Ekuitas|Utang Agregat marang Modal Centogene NV|Total Utang marang Modal ENZ|Total Utang marang Modal fresh2.co FRES|GENE: Rasio Total Utang marang Ekuitas|ME - Utang marang Modal|Rasio Total Utang marang Ekuitas Psychemedics Corporation (PMD)